Moreover, we observed that the expression of FOS (one of the candidate genes and differentially expressed among breast tissues of three distinct statuses) was associated with different pathway variations in para‐cancerous and BC tissues through GSEA, indicating its various functions in BC. This evidence concerns the gene FOS and breast cancer.